Multicenter AIDS Cohort Study

Multicenter AIDS Cohort Study
Name	Multicenter AIDS Cohort Study
Abbreviation	MACS
Discipline	Epidemiology
Start	1984
Status	ongoing
Locations	Baltimore
Principal investigators	Anthony S. Fauci

Multicenter AIDS Cohort Study is a long-standing longitudinal cohort investigating the natural and treated history of human immunodeficiency virus infection among men who have sex with men. Founded in the early 1980s, the study has informed clinical practice, public health policy, and basic science through sustained clinical observation, laboratory research, and collaborative data sharing with universities, hospitals, and federal agencies.

History and Origin

The project began amid the early epidemic context involving institutions such as Johns Hopkins University, University of Pittsburgh, Northwestern University, University of California, Los Angeles, and federal entities including the National Institutes of Health and the Centers for Disease Control and Prevention. Initial leadership included investigators connected to Montreal General Hospital-affiliated research networks and advisors who had worked with figures like Anthony S. Fauci during the emergence of AIDS. The cohort’s founding paralleled events such as the identification of HIV and was contemporaneous with landmark occurrences including the approval of AZT and the activism of groups like ACT UP.

Study Design and Methods

The cohort employs prospective observational design elements influenced by methodologies from studies at Harvard Medical School and Columbia University that use repeated clinical visits, standardized questionnaires, and laboratory assays. Biostatistical frameworks draw on approaches used at Fred Hutchinson Cancer Research Center and Dana-Farber Cancer Institute for survival analysis, longitudinal modeling, and causal inference similar to methods applied in research at Stanford University and Yale University. Laboratory methods incorporated virology techniques paralleling work at Pasteur Institute and immunology assays developed at Scripps Research.

Participant Population and Recruitment

Enrollment strategies mirrored community-engaged recruitment efforts used by programs associated with LGBT Health Center networks, outreach models from Fenway Health, and venue-based sampling used in studies in San Francisco and New York City. The cohort focused on men who have sex with men from metropolitan areas including Baltimore, Chicago, Pittsburgh, and Los Angeles, employing screening and informed consent processes reflective of guidelines from World Health Organization and Office for Human Research Protections standards adopted in clinical research at institutions such as Massachusetts General Hospital.

Key Findings and Contributions

The study produced seminal observations on HIV natural history that informed landmark clinical milestones like antiretroviral therapy optimization and opportunistic infection management used at Beth Israel Deaconess Medical Center. Results contributed to understanding viral load dynamics and CD4 decline, complementary to viral pathogenesis work at Rockefeller University and treatment trials run by National Institute of Allergy and Infectious Diseases. MACS findings intersected with epidemiologic insights from cohorts at San Francisco General Hospital and influenced prevention strategies tied to later trials conducted at Kaiser Permanente and policy deliberations within the Food and Drug Administration and World Health Organization.

Data Collection, Biorepository, and Analysis

The program maintains extensive specimen archives and databases, comparable to biorepositories at Broad Institute and data coordination centers affiliated with Vanderbilt University Medical Center. Specimens and datasets supported genomic, proteomic, and immunologic studies paralleling projects at Cold Spring Harbor Laboratory and Broad Institute collaborations, enabling analyses using platforms developed at Microsoft Research and computational workflows from Lawrence Berkeley National Laboratory and Los Alamos National Laboratory.

Funding, Governance, and Collaborations

Funding streams have included federal grants from the National Institutes of Health and cooperative agreements with the National Institute of Allergy and Infectious Diseases and the National Institute of Child Health and Human Development, alongside philanthropic support resembling grants from foundations such as the Gates Foundation and partnerships with academic centers like University of California, San Francisco and University of Miami. Governance structures reflect oversight mechanisms akin to institutional review boards at Columbia University and data use agreements resembling frameworks used by Johns Hopkins University and multicenter consortia including those led by Fred Hutchinson Cancer Research Center.

Ethical Considerations and Impact on Policy

Ethical review and participant protections aligned with guidance from the Office for Human Research Protections and debates involving activist organizations such as ACT UP and Lambda Legal. Findings informed clinical guidelines and public health recommendations referenced by agencies like the Centers for Disease Control and Prevention and regulatory decisions at the Food and Drug Administration, contributing to shifts in screening, treatment initiation, and long-term care policies implemented in health systems such as Veterans Health Administration and municipal public health departments in Los Angeles and Chicago.

Category:Epidemiological studies